ClinicalTrialsFinder
RecruitingPhase 2NCT07269717

A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial on the Efficacy and Safety of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction

Sponsor

Shandong Suncadia Medicine Co., Ltd.

Enrollment

48 participants

Start Date

Mar 30, 2026

Study Type

INTERVENTIONAL

Conditions

Heart Failure With Preserved Ejection Fraction

Summary

This study aims to evaluate the safety and tolerability of HRS-1893 in subjects with heart failure with preserved ejection fraction.

Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called HRS-1893 Tablet and a drug called HRS-1893 Tablet Placebo for people with heart failure with preserved ejection fraction. The study is currently recruiting participants at 1 location. People eligible for this study include aged 40 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGHRS-1893 Tablet

HRS-1893 tablet.

DRUGHRS-1893 Tablet Placebo

HRS-1893 tablet placebo.

Locations(1)

Zhongshan Hospital Affiliated to Fudan University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07269717

Related Trials

Ketogenic Diet vs Mixed Diet in Patients With Heart Failure

NCT060815431 location

EXercise and Activin Inhibition to Modulate InflammatioN Effects on Heart Failure and Cognition (EXAMINE-HFC)

NCT072020001 location

A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure

NCT070830111 location

A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

NCT072143763 locations

Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction

NCT055256631 location